Arrhythmias in young adults

Česká verzia

Authors: M. Vícha; T. Skála; M. Táborský
Authors place of work: I. interní klinika – kardiologická LF UP a FN Olomouc
Published in the journal: Kardiol Rev Int Med 2018, 20(2): 87-95

Summary

Cardiac arrhythmias are a heterogeneous group of disorders which are common in every age group. The clinical importance depends on the specific type of arrhythmia – from benign forms (a majority of supraventricular tachycardias) to ventricular arrhythmias with a risk of a sudden cardiac death. Rather than a long-term antiarrhythmic prophylaxis, a cardiac electrophysiological examination with endo and/or epicardial catheter ablation is a modern, and in many cases a causal therapy for heart rhythm disorders. Implantation of a cardiac pacemaker or cardioverter-defibrillator is indicated in some selected groups of patients in primary or secondary prevention.

Key words:
arrhythmia – tachycardia – bradycardia – supraventricular tachycardia – ventricular arrhythmias – ventricular fibrillation – sudden cardiac death – cardioverter-defibrillator – catheter ablation – pharmacotherapy – guidelines

Zdroje

1. Kvasnička J, Havlíček A. Arytmologie pro praxi. Praha: Galén 2010.

2. Táborský M, Kautzner J, Linhart A et al. Kardiologie. Praha: Mladá fronta 2017.

3. Čihák R, Haman L, Táborský M et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Summary of the document prepared by the Czech Society of Cardiology. Cor Vasa 2016; 58: e636– e683.

4. 2005 American Heart Association Guidelines for cardiopulmonary resuscitation and emergency cardiovascular care. Management of symptomatic bradycardia and tachycardia. Circulation 2005; 112: IV67– IV77. doi: 10.1161/ CIRCULATIONAHA.105.166558.

5. Češka R et al. Interna. 1. vyd. Praha: Triton 2010.

6. Lévy S, Olshansky B. Arrhythmia management for the primary care clinician. Available at: https:/ / www.uptodate.com/ contents/ arrhythmia-management-for-the-primary-care-clinician.

7. The electrocardiogram, ECG. Nobel Media AB 2014. Available at: https:/ / www.nobelprize.org/ educational/ medicine/ ecg/ .

8. Fiala M. Doporučené postupy pro diagnostiku a léčbu supraventrikulárních tachyarytmií. Česká kardiologická společnost. Cor Vasa 2005; 47 (9 Suppl): 18– 39.

9. Page RL, Joglar JA, Caldwell MA et al. 2015 ACC/ AHA/ HRS Guideline for the management of adult patients with supraventricular tachycardia: executive summary: a report of the American College of Cardiology/ American Heart Association task force on clinical practice guidelines and the Heart Rhythm Society. Circulation 2016; 133(14): e471– e505. doi: 10.1161/ CIR.0000000000000310.

10. Kettner J, Kautzner J et al. Akutní kardiologie. 2. vyd. Praha: Mladá fronta 2017.

11. Rivera S, De La Paz Ricapito M, Conde D et al. The retrograde P-wave theory: explaining ST segment depression in supraventricular tachycardia by retrograde AV node conduction. Pacing Clin Electrophysiol 2014; 37(9): 1100– 1105. doi: 10.1111/ pace.12394.

12. Schueler M, Vafaie M, Becker R et al. Prevalence, kinetic changes and possible reasons of elevated cardiac troponin T in patients with AV nodal re-entrant tachycardia. Acute Card Care 2012; 14(4): 131– 137. doi: 10.3109/ 17482941.2012.741246.

13. Ellis ER, Josephson ME. What about tachycardia-induced Cardiomyopathy? Arrhythm Electrophysiol Rev 2013; 2(2): 82– 90. doi: 10.15420/ aer.2013.2.2.82.

14. Priori SG, Blomström-Lundqvist C, Mazzanti Aet al. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The task force for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J 2015; 36(41): 2793– 2867. doi: 10.1093/ eurheartj/ ehv316.

15. Kautzner J, Osmančík P. Summary of the 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Prepared by the Czech Society of Cardiology. Cor Vasa 2016: 58: e29– e80.

16. Bytešník J, Pařízek P, Wichterle D et al. Komorové arytmie. Doporučený diagnostický a léčebný postup České kardiologické společnosti. Cor Vasa 2011; 53 (Suppl 1): 53– 77.

17. Al-Khatib SM, Stevenson WG, Ackerman MJ et al. 2017 AHA/ ACC/ HRS Guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: executive summary: a report of the American College of Cardiology/ American Heart Association task force on clinical practice guidelines and the Heart Rhythm Society. Circulation 2017; pii: CIR.0000000000000548. doi: 10.1161/ CIR.0000000000000548.

18. Brugada J, Diez DP. How to recognise and manage idiopathic ventricular tachycardia. An article from the e-journal of the ESC Council for Cardiology Practice 2010; 8(26). Available at: https:/ / www.escardio.org/ Journals/ E-Journal-of-Cardiology-Practice/ Volume-8/ How-to-recognise-and-manage-idiopathic-ventricular-tachycardia.

19. Aktas M, Daubert P. Long QT syndrome. BMJ Best Practice. Available at: https:/ / bestpractice.bmj.com.

20. Schwartz PJ, Ackerman MJ. Congenital long QT syndrome: Epidemiology and clinical manifestations. Available at: https:/ / www.uptodate.com/ contents/ congenital-long-qt-syndrome-epidemiology-and-clinical-manifestations.

21. Reviriego SM, Merino JL. Short QT Syndrome. An article from the E-Journal of the ESC Council for Cardiology Practice 2010; 9(2). Available at: https:/ / www.escardio.org/ Journals/ E-Journal-of-Cardiology-Practice/ Volume-9/ Short-QT-Syndrome.

22. Mizusawa Y, Wilde A. Brugada syndrome. Circ Arrhythm Electrophysiol 2012; 5(3): 606– 616. doi: 10.1161/ CIRCEP.111.964577.

23. Elliott PM, Anastasakis A, Borger MA et al. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the task force for the diagnosis and management of hypertrophic cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J 2014; 35(39): 2733– 2779. doi: 10.1093/ eurheartj/ ehu284.

24. Haugaa KH, Haland TF, Leren IS et al. Arrhythmogenic right ventricular cardiomyopathy, clinical manifestations, and diagnosis. Europace 2016; 18(7): 965– 972. doi: 10.1093/ europace/ euv340.

25. Lebl J, Janda J, Pohunek P et al. Klinická pediatrie. 2. vyd. Praha: Galén 2014.

26. Brignole M, Auricchio A, Baron-Esquivias G et al. 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the task force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Eur Heart J 2013; 34(29): 2281– 2329. doi: 10.1093/ eurheartj/ eht150